The Diabetes Herbsttagung 2026 will examine artificial intelligence in diabetes care, immune prevention of type 1 diabetes, GLP-1 receptor agonists and automated insulin delivery, according to a programme preview published by Medical Tribune. The German diabetes autumn conference runs on 13 and 14 November 2026, with sessions scheduled across both days.
Medical Tribune reports that the programme is organised around named symposia, each with designated chairs and speakers, and that the event also carries practical information on registration, certification and travel.
Why it matters
The agenda reflects where clinical diabetes care is heading: toward decision-support tools built on patient data, toward preventive strategies for type 1 diabetes, and toward technology that increasingly takes over insulin dosing decisions. Each of these areas raises questions that go beyond efficacy, including data protection, ethics and law, and whether digital tools benefit all patients equally.
The congress also gives practitioners a structured look at how new systems perform in everyday clinical settings, rather than only in trial conditions.
AI from today's practice to tomorrow's digital twins
One symposium on Friday, 13 November, from 14.45 to 16.15, is chaired by Professor Dr Claudia Eberle of Fulda and addresses digitalisation and artificial intelligence in diabetes care, according to Medical Tribune.
Professor Dr Bernhard Kulzer of Bad Mergentheim is listed to speak on current areas of application in diabetes care as practised today. Professor Eberle's talk looks ahead to AI in diabetes care of the future, framed around digital twins used to support decisions and therapy.
A further presentation examines AI in routine practice, focusing on practical help with practice organisation. The session closes with a talk on AI at the intersection of data protection, ethics and law.
Type 1 diabetes: from study data to immune prevention
A separate symposium turns to prevention of type 1 diabetes. Medical Tribune reports that the session begins with study data and existing gaps in knowledge.
Paediatric diabetologist PD Dr Torben Biester of Braunschweig then discusses the opportunities and risks of immune prevention of type 1 diabetes in childhood. The chances and challenges of such prevention in adults are also presented.
The symposium ends with a panel discussion titled, in German, "How can immune prevention of type 1 diabetes be sensibly implemented?" Professor Seufert and Dr Biester are named as confirmed participants.
GLP-1 receptor agonists in type 1 diabetes
On Saturday, 14 November, from 13.00 to 14.30, a session chaired by Professor Dr Susanne Reger-Tan of Bad Oeynhausen and Dr Jonas Laaser of Hamburg asks what role GLP-1 receptor agonists play in type 1 diabetes.
According to Medical Tribune, the session covers their use in "double diabetes", in obesity and in patients on high insulin doses. Current data on safety, including hypoglycaemia and ketoacidosis, and on effectiveness, including weight, insulin requirement and HbA1c, are to be discussed. A critical comparison with exercise therapy is also planned, with the aim of an evidence-based assessment.
Insulin delivery: from pens and pumps to fully closed loops
Running at the same time on Saturday is a session chaired by Dr Sandra Schlüter of Northeim and Dr Guido Freckmann of Ulm. It traces developments from conventional insulin delivery by syringe and pump through to innovative AID systems and smart insulin pens, and looks at how these are applied in clinical practice.
Medical Tribune reports a particular focus on classifying different AID systems up to the fully closed loop, and on assessing key therapy parameters such as Time in Range and HbA1c and how these differ between systems.
Dr Christine Berndt-Zipfel of Bad Kreuznach is listed to give an overview of AID systems up to the fully closed loop. Dr Manuel Eichenlaub of Ulm presents on Time in Range and HbA1c and the differences between AID systems.
Digital medicine and sex-specific differences
A Friday afternoon symposium from 16.30 to 18.00, chaired by Professor Reger-Tan and Dr Andrea Martini of Berlin, examines how digital technologies are changing diabetology without benefiting everyone equally. It is a joint session of the DDG's digitalisation commission and the DGIM working group on gender-sensitive medicine.
Medical Tribune reports that the session considers how sex-specific differences, hormonal cycles, individual metabolic patterns and adaptive algorithms interact. The aim is to show how digital tools can make diversity visible, support personalised care and open new research questions.
Talks include Professor Dr Petra-Maria Schumm-Draeger of Munich on gender-sensitive internal medicine in the digital age, and Professor Reger-Tan on PMOS, formerly PCOS, as a sex-specific cardiometabolic risk. Dr Martina Rothenbühler of Bern covers hormonal cycles, insulin sensitivity and AID systems, and Professor Dr Julia Szendrödi of Heidelberg discusses menopause, hormones, the heart and glucose in precision medicine.
Registration, childcare and on-demand access
Standard registration runs until 21 October, with late registration from 22 October, according to Medical Tribune. Reduced rates apply for certain professional and participant groups, and students up to the age of 30 attend free of charge.
A Deutsche Bahn event offer is available for travel, and hotel room contingents are held at special conditions. Childcare is offered for children aged 3 to 12, with advance registration required.
To collect all available certification points, attendees must have their participation badge scanned once in the morning and once in the afternoon. The organisers are also converting the meeting into a more climate-friendly event, with measures already in place including paper reduction, environmentally friendly name badges and waste separation.
All symposia are recorded and made available in the DDG Mediathek roughly one hour after presentation for six months, accessible via the booking number. The programme can be planned individually or downloaded as a PDF via the congress website or the DDG app for smartphone and tablet, which also supports live voting.
Watch for the confirmed panel line-up and any programme updates ahead of the 21 October standard registration deadline.
